Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
AIDS (London, England)
|
May 1, 1995
A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial Group
H Jablonowski, K Arasteh, S Staszewski, et al.
The Journal of Infection
|
July 6, 2010
Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65R
C Stephan, B Dauer, M Bickel, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|
January 1, 1988
HIV infection and distribution of GC alleles in AIDS patients, i.v. drug addicts, and hemophiliacs
P Kühnl, S Seidl, G Holzberger, et al.
AIDS (London, England)
|
December 2, 1998
A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects
S Staszewski, C Katlama, T Harrer, et al.
The Journal of Infectious Diseases
|
November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group
A Mocroft, B Ledergerber, J P Viard, et al.
HIV Medicine
|
September 1, 2007
A standardized, comprehensive magnetic resonance imaging protocol for rapid and precise quantification of HIV-1-associated lipodystrophy
M Bickel, J Eisen, C Stephan, et al.
AIDS (London, England)
|
July 14, 2000
Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples
K Hertogs, S Bloor, S D Kemp, et al.
The Journal of Infectious Diseases
|
May 1, 1995
Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitor
S Staszewski, F E Massari, A Kober, et al.
JAMA
|
July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group
S Staszewski, C Loveday, J J Picazo, et al.
The Journal of Infectious Diseases
|
June 2, 1998
Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure
V Miller, A Phillips, C Rottmann, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
AIDS (London, England)
|
May 1, 1995
A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial Group
H Jablonowski, K Arasteh, S Staszewski, et al.
The Journal of Infection
|
July 6, 2010
Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65R
C Stephan, B Dauer, M Bickel, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|
January 1, 1988
HIV infection and distribution of GC alleles in AIDS patients, i.v. drug addicts, and hemophiliacs
P Kühnl, S Seidl, G Holzberger, et al.
AIDS (London, England)
|
December 2, 1998
A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects
S Staszewski, C Katlama, T Harrer, et al.
The Journal of Infectious Diseases
|
November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group
A Mocroft, B Ledergerber, J P Viard, et al.
HIV Medicine
|
September 1, 2007
A standardized, comprehensive magnetic resonance imaging protocol for rapid and precise quantification of HIV-1-associated lipodystrophy
M Bickel, J Eisen, C Stephan, et al.
AIDS (London, England)
|
July 14, 2000
Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples
K Hertogs, S Bloor, S D Kemp, et al.
The Journal of Infectious Diseases
|
May 1, 1995
Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitor
S Staszewski, F E Massari, A Kober, et al.
JAMA
|
July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group
S Staszewski, C Loveday, J J Picazo, et al.
The Journal of Infectious Diseases
|
June 2, 1998
Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure
V Miller, A Phillips, C Rottmann, et al.
Page
of 10